trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Cardiovascular complications associated with COVID-19 vary by vaccination status and vaccine type

the verdict
SUPPORTED
the evidence backs this
Recorded sources
2 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that cardiovascular complications associated with COVID-19 vary by vaccination status and vaccine type?

Yes. Cardiovascular complications following COVID-19 immunization differ across vaccine platforms and dosing schedules, with mRNA vaccines showing distinct patterns of myocarditis and pericarditis compared to vector-based or inactivated options.

Verdict: SUPPORTED · 2 sources for, 0 against · Last checked

The analysis

The claim is specific, empirical, and testable. Retrieved studies such as [3] and [4] explicitly compare cardiovascular complications (like myocarditis and thrombotic events) across different vaccine types (mRNA vs vector-based) and vaccination statuses (such as prime vs. booster doses). All relevant source papers that investigate vaccine-specific cardiovascular outcomes support the assertion that these complication rates vary by vaccine type and status.

Evidence for · 2
Cardiovascular complications of COVID-19 vaccines: A review of case-report and case-series studies
2023
Get citation
Paknahad, M. H., Yancheshmeh, F. B., & Soleimani, A. (2023). Cardiovascular complications of COVID-19 vaccines: A review of case-report and case-series studies. doi.org. https://doi.org/10.1016/j.hrtlng.2023.02.003

See more details
More for · 1
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England
2023
Get citation
Stowe, J., Miller, E., Andrews, N., & Whitaker, H. (2023). Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England. doi.org. https://doi.org/10.1371/journal.pmed.1004245

Related receipts

What does the evidence say?

The claim is specific, empirical, and testable. Retrieved studies such as [3] and [4] explicitly compare cardiovascular complications (like myocarditis and thrombotic events) across different vaccine types (mRNA vs vector-based) and vaccination statuses (such as prime vs. booster doses). All relevant source papers that investigate vaccine-specific cardiovascular outcomes support the assertion that these complication rates vary by vaccine type and status.

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 8504 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work